The DOI matches its Crossref record; 14 of the 16 references it cites were found in a registry or an index.
Decreased SARS-CoV-2 viral load following vaccination
Open accessPreprint — published as 10.1038/s41591-021-01316-7 · Paper page
Abstract
Beyond their substantial protection of individual vaccinees, it is hoped that the COVID-19 vaccines would reduce viral load in breakthrough infections thereby further suppress onward transmission. Here, analyzing positive SARS-CoV-2 test results following inoculation with the BNT162b2 mRNA vaccine, we find that the viral load is reduced 4-fold for infections occurring 12-28 days after the first dose of vaccine. These reduced viral loads hint to lower infectiousness, further contributing to vaccine impact on virus spread.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Some early post-implementation analyses have suggested that the mRNA vaccines also reduce the incidence of asymptomatic infection and the nasopharyngeal viral load in individuals who become infected despite the vaccination93,107, but it is yet unclear how this translates to risk of transmission.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [107]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Temporal dynamics in viral shedding and transmissibility of COVID-19
He, X., Lau, E. H. Y., Wu, P., Deng, X., Wang, J., Hao, X., Lau, Y. C., Wong, J. Y., Guan, Y., Tan, X., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0869-5 · Cited by 4,300
A guide to vaccinology: from basic principles to new developments
Pollard, A. J., & Bijker, E. M. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00479-7 · Cited by 1,593
Rethinking Covid-19 Test Sensitivity — A Strategy for Containment
Mina, M. J., Parker, R., & Larremore, D. B. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2025631 · Cited by 715
SARS-CoV-2 viral load predicts COVID-19 mortality
Pujadas, E., Chaudhry, F. F., McBride, R. B., Richter, F., Zhao, S., Wajnberg, A., Nadkarni, G. N., Glicksberg, B. S., Houldsworth, J., & Cordon‐Cardo, C. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30354-4 · Cited by 534
Evaluation of COVID-19 RT-qPCR Test in Multi sample Pools
Yelin, I., Aharony, N., Tamar, E. S., Argoetti, A., Messer, E., Berenbaum, D., Shafran, E., Kuzli, A., Gandali, N., Shkedi, O., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa531 · Cited by 450
Self-citationUnderstanding COVID-19 vaccine efficacy
Lipsitch, M., & Dean, N. E. (2020) · Science · doi:10.1126/science.abe5938 · Cited by 230
Chodick, G., Tene, L., Patalon, T., Gazit, S., Ben‐Tov, A., Cohen, D., & Muhsen, K. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.15985 · Cited by 189
Self-citationÇevik, M., Marcus, J. L., Buckee, C. O., & Smith, T. C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1442 · Cited by 141
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn
Connors, M., Graham, B. S., Lane, H. C., & Fauci, A. S. (2021) · Annals of Internal Medicine · doi:10.7326/m21-0111 · Cited by 71
Flagged first, then by citations
2 of the 16 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Chodcik, G. et al. The effectiveness of the first dose of BNT162 b 2 vaccine in reducing SARS-CoV-2 infection 13-24 days after immunization: real-world evidence. medRxiv 2021.01.27.21250612 (2021). · DOI
- Levine-Tiefenbrun, M. et al. Association of COVID-19 RT-qPCR test false-negative rate with patient age, sex and time since diagnosis. medRxiv (2020). · DOI
Cited by
Sorted by citations
Items 201–300 of 510
Bilgil, H., Yousef, A., Erciyes, A., Erdinç, Ü., & Öztürk, Z. (2022) · Journal of Computational and Applied Mathematics · doi:10.1016/j.cam.2022.115015 · Cited by 15
Transmission and Risk Factors of COVID-19 among Health Care Workers
Alghader, M., Valvi, D., & de la Hoz, R. E. (2023) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0043-1766118 · Cited by 15
Strafella, C., Caputo, V., Guerrera, G., Termine, A., Fabrizio, C., Cascella, R., Picozza, M., Caltagirone, C., Rossini, A., Balice, M. P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708820 · Cited by 14
Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load
Migueres, M., Dimeglio, C., Trémeaux, P., Raymond, S., Lhomme, S., Da-Silva, I., Oliveira‐Mendes, K., Abravanel, F., Félicé, M.-P., Mansuy, J., et al. (2022) · Viruses · doi:10.3390/v14020323 · Cited by 14
Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities
Liu, S., Kang, M., Zhao, N., Zhuang, Y., Li, S., & Song, T. (2022) · Medical Review · doi:10.1515/mr-2021-0021 · Cited by 15
Vandeputte, J., Damme, P. V., Neyts, J. H., Audonnet, J.-C., Baay, M. F. D., & Neels, P. (2021) · Biologicals · doi:10.1016/j.biologicals.2021.08.001 · Cited by 14
Motta, F. C., McGoff, K. A., Deckard, A., Wolfe, C. R., Bonsignori, M., Moody, M. A., Cavanaugh, K., Denny, T. N., Harer, J., & Haase, S. B. (2021) · JAMA Health Forum · doi:10.1001/jamahealthforum.2021.3035 · Cited by 14
Goethem, N. V., Serrien, B., Vandromme, M., Wyndham-Thomas, C., Catteau, L., Brondeel, R., Klamer, S., Meurisse, M., Cuypers, L., André, E., et al. (2021) · Archives of Public Health · doi:10.1186/s13690-021-00709-x · Cited by 14
Considerations for the Safe Operation of Schools During the Coronavirus Pandemic
Lordan, R., Prior, S., Hennessy, E. J., Naik, A. S., Ghosh, S., Paschos, G. K., Skarke, C., Barekat, K., Hollingsworth, T., Juska, S. A., et al. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.751451 · Cited by 16
Hjörleifsson, K. E., Rögnvaldsson, S., Jónsson, H., Agustsdottir, A. B., Andrésdóttir, M. B., Birgisdottir, K., Eiríksson, Ö., Eyþórsson, E. S., Friðriksdóttir, R., Georgsson, G., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.02.012 · Cited by 15
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases
Trunfio, M., Richiardi, L., Alladio, F., Staffilano, E., Longo, B. M., Venuti, F., Ghisetti, V., Burdino, E., Bonora, S., Vineis, P., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.829393 · Cited by 14
Freitag, T. L., Fagerlund, R., Laham-Karam, N., Leppänen, V., Uğurlu, H., Kant, R., Mäkinen, P. I., Tawfek, A., Jha, S. K., Strandin, T. M., et al. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.04.020 · Cited by 14
Hartnett, G. S., Parker, E. P. K., Gulden, T. R., Vardavas, R., & Kravitz, D. W. (2021) · Journal of Complex Networks · doi:10.1093/comnet/cnab042 · Cited by 15
Saini, A., Li, S., Wang, Z., Plebanski, M., & Ju, Y. (2026) · ACS Nano · doi:10.1021/acsnano.6c00334 · Cited by 15
Geysels, D., Damme, P. V., Verstrepen, W. A., Bruynseels, P., Janssens, B., Smits, P., & Naesens, R. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.326 · Cited by 13
An Outbreak of COVID-19 among mRNA-Vaccinated Nursing Home Residents
Faggiano, F., Rossi, M. A., Cena, T., Milano, F., Barale, A., Ristagno, Q., & Silano, V. (2021) · Vaccines · doi:10.3390/vaccines9080859 · Cited by 12
de Sousa, A. R. V., Silva, L. D. C., de Curcio, J. S., da Silva, H. D., Anunciação, C. E., Salem‐Izacc, S. M., Sanches-Neto, F. O., & Silveira-Lacerda, E. D. P. (2022) · Environmental Science and Pollution Research · doi:10.1007/s11356-022-20609-z · Cited by 13
Vaccine Effect on Household Transmission of Omicron and Delta SARS-CoV-2 Variants
Kim, Y. C., Kim, B., Son, N., Heo, N., Nam, Y., Shin, A., Yang, A. J., Kim, M. H., Kyong, T., Kang, E., et al. (2022) · Journal of Korean Medical Science · doi:10.3346/jkms.2023.38.e9 · Cited by 13
Agent-based model of the impact of higher influenza vaccine efficacy on seasonal influenza burden
Krauland, M. G., Zimmerman, R. K., Williams, K. V., Raviotta, J. M., Harrison, L. H., Williams, J. V., & Roberts, M. S. (2022) · Vaccine X · doi:10.1016/j.jvacx.2022.100249 · Cited by 12
Induction of immune response after SARS-CoV-2 mRNA BNT162b2 vaccination in healthcare workers
Zaffina, S., Alteri, C., Ruggiero, A., Cotugno, N., Vinci, M. R., Camisa, V., Santoro, A. P., Brugaletta, R., Deriu, G. P., Mortari, E. P., et al. (2021) · Journal of Virus Eradication · doi:10.1016/j.jve.2021.100046 · Cited by 13
Voo, T. C., Ballantyne, A., Ng, C. J., Cowling, B. J., Xiao, J., Phang, K. C., Kaur, S., Jenarun, G., Kumar, V., Lim, J. M., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.04.021 · Cited by 15
Ahmed, M. I. M., Diepers, P., Janke, C., Plank, M., Eser, T. M., Rubio‐Acero, R., Fuchs, A., Baranov, O., Castelletti, N., Kroidl, I., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1026473 · Cited by 14
Wong, Y. H. M., Lim, J. T., Griffiths, J., Lee, B., Maliki, D., Thompson, J. R., Wong, M., Chae, S., Teoh, Y. L., Ho, Z. J. M., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.166446 · Cited by 13
Kislaya, I., Rodrigues, E. F., Borges, V., Gomes, J. P., Sousa, C., Almeida, J. P., Peralta‐Santos, A., & Nunes, B. (2021) · medRxiv · doi:10.1101/2021.08.14.21262020 · Cited by 13
Clifford, S., Waight, P., Hackman, J., Hué, S., Gower, C., Kirsebom, F. C. M., Skarnes, C., Letley, L. H., Bernal, J. L., Andrews, N. J., et al. (2021) · medRxiv · doi:10.1101/2021.11.24.21266401 · Cited by 13
Myers, M. A., Dunikoski, L., Brantner, R., Fletcher, D., Saltzberg, E. E., Urdaneta, A. E., Wedro, B. C., & Giwa, A. (2022) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2022.11.005 · Cited by 12
Xue, Y., Chen, D., Smith, S. R., Ruan, X., & Tang, S. (2022) · Bulletin of Mathematical Biology · doi:10.1007/s11538-022-01104-5 · Cited by 12
Sprengholz, P., Korn, L., Eitze, S., & Betsch, C. (2021) · Journal of Medical Ethics · doi:10.1136/medethics-2021-107339 · Cited by 13
Egeren, D. V., Stoddard, M., Novokhodko, A., Rogers, M. S., Joseph‐McCarthy, D., Zetter, B. R., & Chakravarty, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258997 · Cited by 11
Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?
Brüssow, H. (2022) · Microbial Biotechnology · doi:10.1111/1751-7915.14181 · Cited by 13
SARS-CoV-2 breakthrough infections during the second wave of COVID-19 at Pune, India
Doke, P. P., Mhaske, S. T., Oka, G. A., Kulkarni, R., Muley, V., Mishra, A. C., & Arankalle, V. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1040012 · Cited by 12
Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients
Klußmann, J. P., Grosheva, M., Meiser, P., Lehmann, C., Nagy, E., Szijártó, V., Nagy, G., Konrat, R., Flegel, M., Holzer, F., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-32546-z · Cited by 12
Ujjainiya, R., Tyagi, A., Sardana, V., Naushin, S., Bhatheja, N., Kumar, K., Barman, J., Prakash, S., Kutum, R., Bhaskar, A. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29404-3 · Cited by 10
Breakthrough SARS-CoV-2 infections after vaccination: a critical review
Afshar, Z. M., Barary, M., Hosseinzadeh, R., Alijanpour, A., Hosseinzadeh, D., Ebrahimpour, S., Nazary, K., Sio, T. T. W., Sullman, M. J. M., Carson‐Chahhoud, K., et al. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2051412 · Cited by 14
Ivermectin as a potential treatment for COVID-19?
Chosidow, O., Bernigaud, C., Guillemot, D., Giraudeau, B., Lespine, A., Changeux, J., Bourhy, H., Lecuit, M., & Amoura, Z. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009446 · Cited by 11
Müller, L., Andrée, M., Ostermann, P. N., Jazmati, N., Flüh, G., Fischer, J., Bölke, E., Heger, E., Vanshylla, K., Klein, F., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.746644 · Cited by 10
Vaccinating Children against COVID-19: Commentary and Mathematical Modeling
Hawkes, M., & Good, M. F. (2022) · mBio · doi:10.1128/mbio.03789-21 · Cited by 12
Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
Hsu, L. Y., Hurraß, J., Kossow, A., Klobucnik, J., Nießen, J., Wiesmüller, G. A., Grüne, B., & Joisten, C. (2022) · Public Health · doi:10.1016/j.puhe.2022.01.005 · Cited by 12
Goethem, N. V., Vandromme, M., Oyen, H. J. V., Haarhuis, F., Brondeel, R., Catteau, L., André, E., Cuypers, L., Blot, K. Y., & Serrien, B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0269138 · Cited by 11
Modeling disease transmission in a train carriage using a simple 1D ‐model
de Kreij, R. J. B., Wykes, M. S. D., Woodward, H., & Linden, P. F. (2022) · Indoor Air · doi:10.1111/ina.13066 · Cited by 11
Sunagawa, J., Park, H., Kim, K. S., Komorizono, R., Choi, S., Torres, L. R., Woo, J., Jeong, Y. D., Hart, W. S., Thompson, R. N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43043-2 · Cited by 11
Al‐Emran, H. M., Hasan, M. S., Setu, M. A. A., Rahman, M. S., Alam, A. R. U., Sarkar, S. L., Islam, M. T., Islam, M. R., Rahman, M. M., Islam, O. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.12.002 · Cited by 11
Optimal selection of COVID-19 vaccination sites in the Philippines at the municipal level
Cabanilla, K. I., Enriquez, E. A. T., Velasco, A. C., Mendoza, V. M. P., & Mendoza, R. (2022) · PeerJ · doi:10.7717/peerj.14151 · Cited by 12
COVID‐19 vaccines: what do we know so far?
Dhillon, P., Altmann, D. M., & Male, V. H. (2021) · FEBS Journal · doi:10.1111/febs.16094 · Cited by 11
Sprengholz, P., Siegers, R., Goldhahn, L., Eitze, S., & Betsch, C. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114324 · Cited by 10
Caveats on COVID-19 herd immunity threshold: the Spain case
García‐García, D., Morales, E., Fonfría, E. S., Vigo, I., & Bordehore, C. (2022) · Scientific Reports · doi:10.1038/s41598-021-04440-z · Cited by 11
The Effectiveness of Strategies to Contain Sars-Cov-2: Testing, Vaccinations, and NPIs
Gabler, J., Raabe, T., Röhrl, K., & von Gaudecker, H. (2021) · Scientific Reports · doi:10.1038/s41598-022-12015-9 · Cited by 19
de Graaf, M., Langeveld, J., Post, J., Carrizosa, C., Franz, E., Izquierdo-Lara, R. W., Elsinga, G., Heijnen, L., Béen, F. M., van Beek, J., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.163599 · Cited by 10
Port, J. R., Yinda, C. K., Riopelle, J. C., Weishampel, Z. A., Saturday, T. A., Avanzato, V. A., Schulz, J. E., Holbrook, M. G., Barbian, K., Perry-Gottschalk, R., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42346-8 · Cited by 13
Altawalah, H., Alfouzan, W. A., Al-Fadalah, T., & Ezzikouri, S. (2021) · Diagnostics · doi:10.3390/diagnostics11112110 · Cited by 10
Should Breakthrough SARS-CoV-2 Infection Affect Our Confidence in the COVID-19 Vaccines?
Lamptey, E. (2021) · Infection and Chemotherapy · doi:10.3947/ic.2021.0134 · Cited by 10
Bilgin, H., Marku, M., Yılmaz, S. S., Yağcı, A., Sili, U., Can, B., Sarınoğlu, R. C., Mülazımoğlu, L., Haklar, G., Şïrïkçï, Ö., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.03.001 · Cited by 10
COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants
Stefanelli, P., & Rezza, G. (2022) · Vaccines · doi:10.3390/vaccines10060905 · Cited by 10
Warne, B., Enright, J. A., Metaxaki, M., Fuller, S., Samworth, R. J., Weale, G., Holgate, J., Samtani, V., Brierley, C., Aggarwal, D., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-520626/v1 · Cited by 9
Are the conditions met to make COVID-19 vaccination mandatory for healthcare professionals?
Gagneux‐Brunon, A., Botelho-Nevers, É., & Launay, O. (2021) · Infectious Diseases Now · doi:10.1016/j.idnow.2021.06.301 · Cited by 10
An Appraisal of the Current Scenario in Vaccine Research for COVID-19
Chong, W. C., Chellappan, D. K., Shukla, S. D., Peterson, G. M., Patel, R. P., Jha, N. K., Eri, R. D., Dua, K., Tambuwala, M. M., & Shastri, M. D. (2021) · Viruses · doi:10.3390/v13071397 · Cited by 9
Colavita, F., Meschi, S., Gruber, C. E. M., Rueca, M., Vairo, F., Matusali, G., Lapa, D., Giombini, E., Carli, G. D., Spaziante, M., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.815870 · Cited by 9
Ekowo, O. E., Manafa, C. C., Isielu, R. C., Okoli, C. M., Chikodi, I., Onwuasoanya, A., Echendu, S. T., Ihedoro, I., Nwabueze, U. D., & Nwoke, O. C. (2022) · Pan African Medical Journal · doi:10.11604/pamj.2022.41.114.30767 · Cited by 9
Anti-SARS-CoV-2 Antibody Responses 5 Months Post Complete Vaccination of Moroccan Healthcare Workers
Assaid, N., Arich, S., Charoute, H., Akarid, K., Ezzikouri, S., Maaroufi, A., & Sarih, M. (2022) · Vaccines · doi:10.3390/vaccines10030465 · Cited by 12
Potluri, R. C., Kumar, A., Oriol-Mathieu, V., Effelterre, T. P. V., Metz, L., & Bhandari, H. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07723-6 · Cited by 9
Tachita, T., Takahata, T., Yamashita, S., Ebina, T., Kamata, K., Yamagata, K., Tamai, Y., & Sakuraba, H. (2023) · International Journal of Hematology · doi:10.1007/s12185-023-03607-w · Cited by 9
Orsi, A., Domnich, A., Pace, V. D., Ricucci, V., Caligiuri, P., Bottiglieri, L., Vagge, R., Cavalleri, M., Orlandini, F., Bruzzone, B. M., et al. (2021) · Vaccines · doi:10.3390/vaccines9060591 · Cited by 9
High association of COVID-19 severity with poor gut health score in Lebanese patients
Kassaa, I. A., Omari, S. A., Abbas, N., Papon, N., Drider, D., Kassem, I. I., & Osman, M. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258913 · Cited by 10
Aguas, R. J., Bharath, A., White, L. J., Gao, B., Pollard, A. J., Voysey, M., & Shretta, R. (2021) · Nature Communications · doi:10.1038/s41467-021-26449-8 · Cited by 9
Trunfio, M., Verga, F., Ghisetti, V., Burdino, E., Emanuele, T., Bonora, S., Perri, G. D., & Calcagno, A. (2021) · Vaccines · doi:10.3390/vaccines9121377 · Cited by 10
Sachdev, D. D., Ng, R. C., Sankaran, M., Ernst, A., Hernandez, K., Servellita, V., Sotomayor-González, A., Stoltey, J. E., Cohen, S. E., Nguyen, T. Q., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab1042 · Cited by 8
mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic
Chen, P., Shi, X., He, W., Zhong, G., Tang, Y., Wang, H., & Zhang, P. (2022) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2022.2040330 · Cited by 10
Modeling the Influence of Vaccine Administration on COVID-19 Testing Strategies
Forde, J. E., & Ciupe, S. M. (2021) · Viruses · doi:10.3390/v13122546 · Cited by 9
Bajpai, J., Kant, S., Verma, A. K., Patwa, A. K., Atam, V., Chaudhary, S. C., & Pandey, A. K. (2022) · Cureus · doi:10.7759/cureus.25378 · Cited by 9
Prerequisite for COVID-19 Prediction: A Review on Factors Affecting the Infection Rate
Tang, S. G. H., Hadi, M. H. H., Arsad, S. R., Ker, P. J., Ramanathan, S., Afandi, N. A. M., Afzal, M. M., Yaw, M. W., Krishnan, P. S., Chen, C. P., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192012997 · Cited by 10
Tokyo olympics, Hajj pilgrimage, Grand Magal of Touba and COVID-19
Hoang, V. T., Goumballa, N., Al‐Tawfiq, J. A., Sokhna, C., & Gautret, P. (2021) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2021.102088 · Cited by 9
Nucleocapsid-specific humoral responses improve the control of SARS-CoV-2Preprint
Dangi, T., Sanchez, S., Park, M.-C., Class, J., Richner, M., Richner, J. M., & Penaloza‐MacMaster, P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.09.483635 · Cited by 9
Krüger, L. J., Lindner, A. K., Gaeddert, M., Tobian, F., Klein, J. A. F., Steinke, S., Lainati, F., Schnitzler, P., Nikolai, O., Mockenhaupt, F. P., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01229-22 · Cited by 8
Protective effect of vaccination on the risk of cardiovascular disease after SARS-CoV-2 infection
Song, J., Choi, S., Jeong, S., Chang, J. Y., Park, S. J., Oh, Y. H., Kim, J. S., Cho, Y., Byeon, K., Choi, J. Y., et al. (2023) · Clinical Research in Cardiology · doi:10.1007/s00392-023-02271-8 · Cited by 11
SARS-CoV-2 Transmission Risk to Household and Family Contacts by Vaccinated Healthcare Workers
Pratò, S., Paladino, M. E., Riva, M. A., Deni, M., & Belingheri, M. (2021) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0000000000002238 · Cited by 8
Dimeglio, C., Milhes, M., Loubes, J., Ranger, N., Mansuy, J., Trémeaux, P., Jeanne, N., Latour, J., Nicot, F., Donnadieu, C., et al. (2021) · Viruses · doi:10.3390/v13050898 · Cited by 8
COVID-19 herd immunity v. learning to live with the virus
Madhi, S. A. (2021) · South African Medical Journal · doi:10.7196/samj.2021.v111i9.16005 · Cited by 7
Schulte, B., Marx, B., Korencak, M., Emmert, D., Aldabbagh, S., Eis-Hübinger, A., & Streeck, H. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.704719 · Cited by 7
Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
Mohanraj, D., Baldwin, S., Singh, S., Gordon, A., & Whitelegg, A. M. E. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104501 · Cited by 10
Singh, B. K., Walker, J. W., Paul, P., Reddy, S. C., Gowler, C. D., Jernigan, J. A., & Slayton, R. B. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.04.040 · Cited by 8
Healthcare Professionals’ Ethical Responsibility in COVID-19 Vaccination Decision-Making
Zolkefli, Y. (2022) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2022.29.2.14 · Cited by 9
Influence of Nasopharyngeal Viral Load on the Spread of the Omicron BA.2 Variant
Migueres, M., Dimeglio, C., Mansuy, J., Abravanel, F., Raymond, S., Latour, J., Jeanne, N., Ranger, N., Lhomme, S., Sauné, K., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac563 · Cited by 8
Genetic Load of SARS-CoV-2 in Aerosols Collected in Operating Theaters
Barberá-Riera, M., Porru, S., Barneo‐Muñoz, M., Ferrer, A. V., Carrasco, P., de Llanos, R., Llueca, A., & Delgado-Saborit, J. M. (2022) · Applied and Environmental Microbiology · doi:10.1128/aem.01297-22 · Cited by 8
Dimcheff, D. E., Blair, C. N., Zhu, Y., Chappell, J. D., Gaglani, M., McNeal, T., Ghamande, S. A., Steingrub, J. S., Shapiro, N. I., Duggal, A., et al. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiad061 · Cited by 8
Combination Therapy with UV-4B and Molnupiravir Enhances SARS-CoV-2 Suppression
Franco, E. J., Drusano, G. L., Hanrahan, K. C., Warfield, K. L., & Brown, A. N. (2023) · Viruses · doi:10.3390/v15051175 · Cited by 8
Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study
Mathema, B., Chen, L., Chow, K. F., Zhao, Y., Zody, M. C., Mediavilla, J. R., Cunningham, M. H., Composto, K., Lee, A., Oschwald, D. M., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01882-21 · Cited by 7
Suliman, S., Matias, W. R., Fulcher, I., Molano, F. J., Collins, S., Uceta, E., Zhu, J., Paxton, R. M., Gonsalves, S. F., Harden, M. V., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-25266-3 · Cited by 8
Kain, D. C., Stall, N. M., Allen, V. G., Evans, G. A., Hopkins, J. P., Kouyoumdjian, F. G., McGeer, A., Mubareka, S., Patel, S. N., Rochon, P. A., et al. (2021) · doi:10.47326/ocsat.2021.02.15.1.0 · Cited by 8
Who Doesn’t Want to be Vaccinated? Determinants of Vaccine Hesitancy During COVID-19Preprint
Dabla‐Norris, E., Khan, H., Lima, F., & Sollaci, A. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4007506 · Cited by 8
Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications
Orendáčová, M., & Kvašňák, E. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.903568 · Cited by 7
Mattarozzi, K., Bagnis, A., Kłosowska, J., Bąbel, P., Cremonini, V., Palma, A. D., Fabbri, A., Farinella, E., Puccini, L., Sambri, V., et al. (2023) · Psychological Science · doi:10.1177/09567976231163875 · Cited by 7
Jang, J., Jeong, H., Kim, B.-H., An, S., Yang, H.-R., & Kim, S. (2023) · PLoS ONE · doi:10.1371/journal.pone.0290154 · Cited by 7
Magalis, B. R., Rich, S. N., Tagliamonte, M. S., Mavian, C. N., Cash, M. N., Riva, A., Marini, S., Amador, D. M., Zhang, Y., Shapiro, J., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac197 · Cited by 7
Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy
Fierro, A., Romano, S., & Antonella Liccardo, B. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265159 · Cited by 9
Oberste, M., Pusch, L.-M., Roth, R., Shah‐Hosseini, K., Schmitz, J., Heger, E., Dewald, F., Müller, C., von Goltzheim, L. S., Lehmann, C., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-13745-1 · Cited by 7
Gillot, C., Bayart, J., Closset, M., Cabo, J., Maloteau, V., Dogné, J., Douxfils, J., & Favresse, J. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2023-0134 · Cited by 9
Hunziker, P. (2021) · Precision Nanomedicine · doi:10.33218/001c.26101 · Cited by 7
Modeling SARS-CoV-2 propagation using rat coronavirus-associated shedding and transmission
Zeiss, C. J., Asher, J. L., Wyk, B. V., Allore, H. G., & Compton, S. R. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260038 · Cited by 6
Singanayagam, A., Hakki, S., Dunning, J. W., Madon, K. J., Crone, M. A., Koycheva, A., Derqui, N., Barnett, J. L., Whitfield, M. G., Varro, R., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3918287 · Cited by 7
Public health-focused use of COVID-19 rapid antigen and PCR tests
Woodbridge, Y., Goldberg, Y., Amit, S., Kopelman, N. M., Mandel, M., & Huppert, A. (2024) · Scientific Reports · doi:10.1038/s41598-023-50533-2 · Cited by 6
Metadata
- Authors
- Levine-Tiefenbrun, M., Yelin, I., Katz, R., Herzel, E., Golan, Z., Schreiber, L., Wolf, T., Nadler, V., Ben-Tov, A., Kuint, J., Gazit, S., Patalon, T., Chodick, G., & Kishony, R.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- Maccabi Healthcare Services (IL)
- Tel Aviv University (IL)
- Corresponding author
- Yelin, Idan
- Kishony, Roy
- ORCID
- Venue
- Nature Medicine
- Publisher
- openRxiv
- Published
- 2021-02-08
- Volume
- 27
- Issue
- 5
- Pages
- 790-792
- ISSN
- 1078-8956 (ISSN-L)
- OpenAlex
- W3150351745
- Cited by
- 514
- References
- 16
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 19 · 2023: 67 · 2022: 166 · 2021: 242
- FWCI
- 39.10
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Nature Medicine (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Israel Science Foundation (3633/19)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, BNT162b2, mRNA vaccines, breakthrough infection, viral load, infectiousness, transmission reduction, vaccine effectiveness, real-world data
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, BNT162 Vaccine, Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Vaccination, Viral Load, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
